IWM
HALO icon

IHT Wealth Management’s Halozyme HALO Stock Holding History

IHT Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,170
Closed -$264K – 848
2020
Q4 		$264K Buy
+6,170
New +$222K 0.02% 601
2018
Q2 		– Sell
-200
Closed -$4K – 817
2018
Q1 		$4K Hold
200
– – ﹤0.01% 1382
2017
Q4 		$4K Buy
+200
New +$3.68K ﹤0.01% 1380

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IHT Wealth Management's HALO Position: Q1 2021 in Review

IHT Wealth Management sold out of Halozyme (HALO) in Q1 2021, closing a stake of 6,170 shares — an estimated $264K sold.

IHT Wealth Management first reported a position in HALO in Q4 2017 and held it in 3 quarters. The position peaked at $264K in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

  • IHT Wealth Management reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
  • IHT Wealth Management sold 6,170 Halozyme shares in Q1 2021, an estimated $264K.
  • IHT Wealth Management first reported a position in Halozyme in Q4 2017 and held it in 3 quarters.
  • IHT Wealth Management's Halozyme position peaked at $264K in Q4 2020.
  • 336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on IHT Wealth Management's 13F filing for Q1 2021, filed 18 May 2021.